Aldo-keto reductase family member C3 (AKR1C3) promotes hepatocellular carcinoma cell growth by producing prostaglandin F2α
Article in Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (January 2024)
The most recent citing publications are shown below. View all 110 publications that cite this research output on Dimensions.
AKR1C3 Converts Castrate and post-Abiraterone DHEA-S into Testosterone to Stimulate Growth of Prostate Cancer Cells via 5-Androstene-3β,17β-Diol
Article in Cancer Research Communications (September 2023)
Targeting sex steroid biosynthesis for breast and prostate cancer therapy
Article in Nature Reviews Cancer (September 2023)